Twentieth century medicine has been rife with major technological developments that has led to improved healthcare provision. However, we still have a long way to go in terms of giving individualized care to patients based on their needs and circumstances to truly have a positive impact on health.

Treatment of congenital heart diseases has been fraught with complications but most if not all challenges have been solved with innovation. These huge leaps in medical advancement have led to a significant change in patient outcomes. However, some challenges still remain for healthcare providers and patients.

The boom in technological advancements in twentieth century have made it an integral part of our lives. However, not everyone has equal access to it.

Many communities such as individuals with Down syndrome (DS) find it difficult to maneuver through the tech landscape because of a lack of inclusive features. Existing research in Universal Accessibility related to individuals with DS is quite limited.

Warfarin is a medication that is prescribed to patients to prevent blood clots in conditions such as heart attacks, strokes, pulmonary embolism, venous thrombosis and many more. (1) Warfarin prescription can be a lifesaving intervention for many; however, it does pose some challenges that both the patient and care provider need to be wary of.

Warfarin is an important drug which has been used extensively to treat conditions of hypercoagulability. In terms of its use and therapeutic effect, it is one of the most effective drugs in the market today, however, it requires special considerations from clinical practitioners due to its adverse effects.